戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lasmodium control and that crosstalk between co-inhibitory and co-stimulatory pathways in pathogen-sp
2                                Modulation of co-inhibitory and co-stimulatory receptors of the immune
3 , a member of the B7 family of costimulatory/co-inhibitory ligands expressed by both malignant cells
4 imately 50% of Tc17 cells also expressed the co-inhibitory molecule CTLA-4, and only a minority (<20%
5 dent upon sustained T cell expression of the co-inhibitory molecule PD-1.
6  the first genetic evidence that BTN2A2 is a co-inhibitory molecule that modulates T cell-mediated im
7                           Interestingly, the co-inhibitory molecules cytotoxic T lymphocyte antigen-4
8                                              Co-inhibitory molecules play a major role in modulating
9  PD-L1(+) DC, MDSC, TAM and Treg, as well as co-inhibitory molecules-double-positive, severely exhaus
10 lves a complex network of co-stimulatory and co-inhibitory molecules.
11                While therapies targeting the co-inhibitory or immune checkpoint receptors PD-1 and CT
12 d side effects, suggesting the importance of co-inhibitory pathway for both prevention of autoimmunit
13 ptor and its ligands, PD-L1 and PD-L2, are a co-inhibitory pathway that contributes to the negative r
14 will focus on the role of co-stimulatory and co-inhibitory pathways in two systemic (systemic lupus e
15 which is a large array of co-stimulatory and co-inhibitory pathways that modulate the host response.
16  these might be increased by blocking T-cell co-inhibitory pathways, such as preventing interaction b
17 ogated following coordinate blockade of PD-1 co-inhibitory pathways, which are also upregulated durin
18 incident with selective upregulation of CD85 co-inhibitory pathways.
19 12 application with systemic blockade of the co-inhibitory receptor CTLA-4 on T cells led to tumor er
20                             Mice lacking the co-inhibitory receptor cytotoxic T lymphocyte antigen-4
21 tting of chronic diseases where constitutive co-inhibitory receptor expression on T cells dampens eff
22 une restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) during
23 tes various immune responses by engaging the co-inhibitory receptor programmed death-1.
24 e binding affinities of the PD-1-PD-L1/PD-L2 co-inhibitory receptor system, and discovered an unexpec
25                             The next wave of co-inhibitory receptor targets that are being explored i
26  effects of programmed cell death 1 (PD1), a co-inhibitory receptor that impairs T-cell function and
27    B and T lymphocyte attenuator (BTLA) is a co-inhibitory receptor that interacts with herpesvirus e
28                                   Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-produc
29 d by the constellation of co-stimulatory and co-inhibitory receptors expressed on the cell surface.
30 at occur in cancer, highlighting the role of co-inhibitory receptors in contributing to this process
31                                 However, all co-inhibitory receptors share an ability to oppose activ
32 f CD57 and loss of CD28, with an increase in co-inhibitory receptors such as PD-1 and Tim-3.
33  This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhan
34 -domain molecule 3 (Tim-3), which are potent co-inhibitory receptors, and their persistent expression
35                                              Co-inhibitory receptors, such as CTLA-4 and PD-1, have a
36 s exist to limit Akt activation by different co-inhibitory receptors.
37 s but potentially between co-stimulatory and co-inhibitory receptors.
38 on of multiple additional co-stimulatory and co-inhibitory receptors.
39  prominent sites of synapsis initiation, and CO-inhibitory role(s) that limit CO number.
40  the recent advances in our understanding of co-inhibitory signaling and its potential clinical appli
41                      In addition to blocking co-inhibitory signals in secondary lymphoid organs, cyto
42  Here, we identified a critical role for the co-inhibitory SLAM family member 2B4 (CD244) in attenuat

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。